Bio-Thera Solutions Inc. (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative ...

Bio-Thera had entered into an exclusive licensing agreement with STADA Arzneimittel AG to commercialize BAT2506 in the European Union (UK), the United Kingdom (UK), Switzerland, and selected other ...

Imfinzi recommended for approval in European Union for the treat of adults with limited-stage small cell lung cancer ...

Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...

Anthony Harnden took up his new role as the chair of the Medicines and Healthcare products Regulatory Agency (MHRA) at the ...

AMSTERDAM (Reuters) - The European Medicines Agency (EMA) said on Monday it would ... as it decided on the use of vaccines in the European Union. The European Commission and other EU institutions ...

The European Medicines Agency (EMA) said on Monday it would no longer post on X and would use rival Bluesky instead, becoming the latest organisation to quit a social media platform that some have ...

The EMA anticipates that the ability to access scientific advice will foster innovation among medical device manufacturers.

Acceptance follows resolution of third-party fill/finish manufacturing issuesFDA decision expected by July 10, 2025 TARRYTOWN, N.Y., Feb. 11, ...

to the European Medicines Agency (EMA) for trofinetide for the treatment of Rett syndrome in adults and pediatric patients two years of age and older. If granted marketing authorization ...

Europeans are being warned of the dangers of counterfeit medications after police squads across the continent reported ...